K, E., F, G., NS, J., C, B., SN, P., V, S., . . . M, P. (2023). A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. Frontiers in pharmacology, 14, 1140656. https://doi.org/10.3389/fphar.2023.1140656
Chicago Style (17th ed.) CitationK, Egger, et al. "A Pilot Study of Cerebral Metabolism and Serotonin 5-HT2A Receptor Occupancy in Rats Treated with the Psychedelic Tryptamine DMT in Conjunction with the MAO Inhibitor Harmine." Frontiers in Pharmacology 14 (2023): 1140656. https://doi.org/10.3389/fphar.2023.1140656.
MLA (9th ed.) CitationK, Egger, et al. "A Pilot Study of Cerebral Metabolism and Serotonin 5-HT2A Receptor Occupancy in Rats Treated with the Psychedelic Tryptamine DMT in Conjunction with the MAO Inhibitor Harmine." Frontiers in Pharmacology, vol. 14, 2023, p. 1140656, https://doi.org/10.3389/fphar.2023.1140656.